2025-04-08 18:26:07
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
ANG Lifesciences India Ltd Q3 FY2021-22 consolidated PAT falls to Rs. 1.33 crore
Posted On : 2022-02-17 19:12:14( TIMEZONE : IST )
ANG Lifesciences India Ltd has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 49.7660 crores during the period ended December 31, 2021 as compared to Rs. 89.5635 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 1.3374 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 12.8668 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 1.29 for the period ended December 31, 2021 as compared to Rs. 12.41 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 49.7660 crs | ₹89.5635 crs |  -44.43% |
| Net Profit | ₹1.3374 crs | ₹12.8668 crs | -89.61% |
| EPS | ₹1.29 | ₹12.41 | -89.61% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 49.7660 crores during the period ended December 31, 2021 as compared to Rs.32.2557 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.1.3374 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.0.0428 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.1.29 for the period ended December 31, 2021 as compared to Rs.0.08 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 49.7660 crs | ₹32.2557 crs |  54.29% |
| Net Profit | ₹1.3374 crs | ₹0.0428 crs | 3,024.77% |
| EPS | ₹1.29 | ₹0.08 | 1,512.50% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.259.2559 crores during the 9 Months period ended December 31, 2021 as compared to Rs.118.5099 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.35.1679 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.5.1293 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.33.92 for the 9 Months period ended December 31, 2021 as compared to Rs.9.90 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹259.2559 crs | ₹118.5099 crs | 118.76% |
| Net Profit | ₹35.1679 crs | ₹5.1293 crs | 585.63% |
| EPS | ₹33.92 | ₹9.90 | 242.63% |
Shares of ANG Lifesciences India Ltd was last trading in BSE at Rs. 237.65 as compared to the previous close of Rs. 226.35. The total number of shares traded during the day was 135850 in over 813 trades.
The stock hit an intraday high of Rs. 237.65 and intraday low of 215.05. The net turnover during the day was Rs. 30462181.00.
